Alamar Biosciences Sees FY2026 Sales $116.000M-$120.000M vs $113.259M Est
Benzinga Newsdesk 2 months ago
NewsGuidance
Alamar Biosciences (NASDAQ:ALMR) sees FY2026 sales of $116.000 million-$120.000 million vs $113.259 million analyst estimate.
Alamar Biosciences (NASDAQ:ALMR) sees FY2026 sales of $116.000 million-$120.000 million vs $113.259 million analyst estimate.